Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-23-002321
Filing Date
2023-01-09
Accepted
2023-01-09 17:01:19
Documents
1
Period of Report
2023-01-05

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm232787-7_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm232787-7_4seq1.xml 4 10430
  Complete submission text file 0001104659-23-002321.txt   11828
Mailing Address 100 WASHINGTON BOULEVARD STAMFORD CT 06902
Business Address 100 WASHINGTON BOULEVARD STAMFORD CT 06902 203-883-9490
SpringWorks Therapeutics, Inc. (Issuer) CIK: 0001773427 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O SPRINGWORKS THERAPEUTICS, INC. 100 WASHINGTON BLVD. STAMFORD CT 06902
Business Address
Edris Badreddin (Reporting) CIK: 0001786966 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39044 | Film No.: 23518777